19-10310597-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001397406.1(FDX2):c.441G>A(p.Ser147=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0037 in 1,613,140 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0038 ( 10 hom. )
Consequence
FDX2
NM_001397406.1 synonymous
NM_001397406.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.457
Genes affected
FDX2 (HGNC:30546): (ferredoxin 2) This gene encodes a member of the ferredoxin family. The encoded protein contains a 2Fe-2S ferredoxin-type domain and is essential for heme A and Fe/S protein biosynthesis. Mutation in FDX1L gene is associated with mitochondrial muscle myopathy. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 19-10310597-C-T is Benign according to our data. Variant chr19-10310597-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 384778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX2 | NM_001397406.1 | c.441G>A | p.Ser147= | synonymous_variant | 5/5 | ENST00000393708.3 | NP_001384335.1 | |
FDX2-ZGLP1 | NR_176051.1 | n.460G>A | non_coding_transcript_exon_variant | 5/8 | ||||
FDX2-ZGLP1 | NR_176052.1 | n.521G>A | non_coding_transcript_exon_variant | 5/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX2 | ENST00000393708.3 | c.441G>A | p.Ser147= | synonymous_variant | 5/5 | 1 | NM_001397406.1 | ENSP00000377311 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00246 AC: 372AN: 151276Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
372
AN:
151276
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00239 AC: 599AN: 251058Hom.: 0 AF XY: 0.00261 AC XY: 354AN XY: 135840
GnomAD3 exomes
AF:
AC:
599
AN:
251058
Hom.:
AF XY:
AC XY:
354
AN XY:
135840
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00383 AC: 5592AN: 1461752Hom.: 10 Cov.: 32 AF XY: 0.00371 AC XY: 2696AN XY: 727180
GnomAD4 exome
AF:
AC:
5592
AN:
1461752
Hom.:
Cov.:
32
AF XY:
AC XY:
2696
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00246 AC: 372AN: 151388Hom.: 0 Cov.: 31 AF XY: 0.00223 AC XY: 165AN XY: 73962
GnomAD4 genome
AF:
AC:
372
AN:
151388
Hom.:
Cov.:
31
AF XY:
AC XY:
165
AN XY:
73962
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | FDX2: BP4, BP7 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at